Deutsche Bank
ALNA

Deutsche Bank’s Allena Pharmaceuticals ALNA Stock Holding History

Deutsche Bank’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-450,673
Closed -$1.23M – 5025
2019
Q4 		$1.23M Buy
+450,673
New +$1.48M ﹤0.01% 2253
2019
Q3 		– Sell
-3,533
Closed -$13K – 5417
2019
Q2 		$13K Sell
3,533
-17,277
-83% -$94.4K ﹤0.01% 4919
2019
Q1 		$144K Sell
20,810
-7,213
-26% -$52.3K ﹤0.01% 4176
2018
Q4 		$151K Sell
28,023
-928
-3% -$8K ﹤0.01% 4024
2018
Q3 		$312K Sell
28,951
-88,074
-75% -$968K ﹤0.01% 4027
2018
Q2 		$1.52M Buy
117,025
+110,068
+1,582% +$1.59M ﹤0.01% 3137
2018
Q1 		$75K Sell
6,957
-4,889
-41% -$40.8K ﹤0.01% 4623
2017
Q4 		$118K Buy
+11,846
New +$146K ﹤0.01% 4205

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Deutsche Bank's ALNA Position: Q1 2020 in Review

Deutsche Bank sold out of Allena Pharmaceuticals (ALNA) in Q1 2020, closing a stake of 450,673 shares — an estimated $1.23M sold.

Deutsche Bank first reported a position in ALNA in Q4 2017 and held it in 8 quarters. The position peaked at $1.52M in Q2 2018. 29 funds tracked by Wall St. Rank hold ALNA as of Q1 2020.

  • Deutsche Bank reported no remaining Allena Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 450,673 Allena Pharmaceuticals shares in Q1 2020, an estimated $1.23M.
  • Deutsche Bank first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 8 quarters.
  • Deutsche Bank's Allena Pharmaceuticals position peaked at $1.52M in Q2 2018.
  • 29 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.